| COMPOSITION: | Each sachet contains L-Ornithine L-Aspartate 3 g |
| FORMULATION: | ORAL POWDER |
| STATUS: | PRESCRIPTION ONLY DRUG |
| DESCRIPTION: | Heplofit contains L-Ornithine l-Aspartate which increases the levels of ornithine and aspartic acid in the body, these amino acids help to reduce levels of ammonia in the blood. This helps in regeneration of damaged liver cells which helps liver to carry out its functions smoothly. Heplofit is used in the treatment of diseases associated with impaired hepatic function (e.g. cirrhosis of the liver), when there are symptoms and signs of minimal or overt hepatic encephalopathy especially for the treatment of incipient loss (Pre coma) or clouding of consciousness (coma). |
| SIDE EFFECTS: | Common side effects may include: Nausea, vomiting, cough, muscle cramping, and diarrhea |
| DOSAGE/DIRECTIONS FOR USE: | As Prescribed by Physician |
